Judge Reverses Precedex Patent Invalidation Following Deal
The deal, struck this past December, permits Sandoz to launch its generic version of the sedative next December.
The complaint, first filed in 2009, accuses the company of violating Hospira and Finland-based Orion Corp.’s jointly owned U.S. Patent No. 6,716,867 — the patent-at-issue in...
To view the full article, register now.